During the past decade, WellSpan Medical Oncology and Hematology conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "WellSpan Medical Oncology and Hematology" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "WellSpan Medical Oncology and Hematology" are "Stage IV Lung Cancer AJCC v8" (5 trials), "Stage IIIB Lung Cancer AJCC v8" (4 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials), "Metastatic Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials) and "Recurrent Lung Non-Small Cell Carcinoma" (2 trials). Many other conditions were trialed in "WellSpan Medical Oncology and Hematology" in a lesser frequency.

Most popular intervention types in "WellSpan Medical Oncology and Hematology" are "Drug" (12 trials), "Procedure" (8 trials), "Biological" (7 trials), "Other" (7 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (7 trials), "Computed Tomography" (6 trials), "Pembrolizumab" (5 trials), "Carboplatin" (4 trials) and "Magnetic Resonance Imaging" (4 trials). Other intervention names were less common.

The vast majority of trials in "WellSpan Medical Oncology and Hematology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "WellSpan Medical Oncology and Hematology". undefined are not yet recruiting, 11 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in WellSpan Medical Oncology and Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in WellSpan Medical Oncology and Hematology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".